When brucine was treated with gemcitabine in MCF-7 breast cancer cells, the results showed that they could synergistically inhibit cancer cell growth and migration, as well as brucine also inhibited the expression of NF-κB p65 in MCF-7 cells [323]. This evidence concerns the gene NFKB1 and breast cancer.